Taruya A, Ota S, Shiono Y, Yamano T, et al. Dapagliflozin Reduces Epicardial Adipose Tissue and Myocardial Fibrosis in Subclinical Heart Failure: The DAPA-EAT Trial. Circulation 2025 Nov 9. doi: 10.1161/CIRCULATIONAHA.125.077630.
PMID: 41206791